Statement Of Cash Flows [Abstract]

Zealand Pharma - Filing #1382971

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
10,263,000 EUR
166,325,000 EUR
97,818,000 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of investments other than investments accounted for using equity method
887,060,000 EUR
0 EUR
0 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of warrants
23,836,000 EUR
26,070,000 EUR
41,363,000 EUR
Payments for share issue costs
47,456,000 EUR
46,895,000 EUR
42,706,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.